489 related articles for article (PubMed ID: 14722654)
1. Modulation of insulin action.
Pirola L; Johnston AM; Van Obberghen E
Diabetologia; 2004 Feb; 47(2):170-84. PubMed ID: 14722654
[TBL] [Abstract][Full Text] [Related]
2. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
Gual P; Le Marchand-Brustel Y; Tanti JF
Biochimie; 2005 Jan; 87(1):99-109. PubMed ID: 15733744
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
[TBL] [Abstract][Full Text] [Related]
4. Modulators of insulin action and their role in insulin resistance.
Pirola L; Johnston AM; Van Obberghen E
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S61-4. PubMed ID: 14704748
[TBL] [Abstract][Full Text] [Related]
5. Activation of SOCS-3 by resistin.
Steppan CM; Wang J; Whiteman EL; Birnbaum MJ; Lazar MA
Mol Cell Biol; 2005 Feb; 25(4):1569-75. PubMed ID: 15684405
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
Kawaguchi T; Yoshida T; Harada M; Hisamoto T; Nagao Y; Ide T; Taniguchi E; Kumemura H; Hanada S; Maeyama M; Baba S; Koga H; Kumashiro R; Ueno T; Ogata H; Yoshimura A; Sata M
Am J Pathol; 2004 Nov; 165(5):1499-508. PubMed ID: 15509521
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
Ueki K; Kondo T; Kahn CR
Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
[TBL] [Abstract][Full Text] [Related]
8. The IRS-signalling system: a network of docking proteins that mediate insulin action.
White MF
Mol Cell Biochem; 1998 May; 182(1-2):3-11. PubMed ID: 9609109
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.
Carey AL; Steinberg GR; Macaulay SL; Thomas WG; Holmes AG; Ramm G; Prelovsek O; Hohnen-Behrens C; Watt MJ; James DE; Kemp BE; Pedersen BK; Febbraio MA
Diabetes; 2006 Oct; 55(10):2688-97. PubMed ID: 17003332
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of IRS proteins, insulin action, and insulin resistance.
Boura-Halfon S; Zick Y
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E581-91. PubMed ID: 18728222
[TBL] [Abstract][Full Text] [Related]
11. IRS-1 regulation in health and disease.
Schmitz-Peiffer C; Whitehead JP
IUBMB Life; 2003 Jul; 55(7):367-74. PubMed ID: 14584587
[TBL] [Abstract][Full Text] [Related]
12. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
13. [Insulin signalling system and mechanism of insulin resistance].
Hino Y; Ogawa W; Kasuga M
Nihon Rinsho; 2000 Feb; 58(2):297-303. PubMed ID: 10707548
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling.
Fiory F; Alberobello AT; Miele C; Oriente F; Esposito I; Corbo V; Ruvo M; Tizzano B; Rasmussen TE; Gammeltoft S; Formisano P; Beguinot F
Mol Cell Biol; 2005 Dec; 25(24):10803-14. PubMed ID: 16314505
[TBL] [Abstract][Full Text] [Related]
15. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
16. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
Le MN; Kohanski RA; Wang LH; Sadowski HB
Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
[TBL] [Abstract][Full Text] [Related]
17. Developmental regulation of the activation of signaling components leading to translation initiation in skeletal muscle of neonatal pigs.
Suryawan A; Escobar J; Frank JW; Nguyen HV; Davis TA
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E849-59. PubMed ID: 16757550
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.
Duan C; Yang H; White MF; Rui L
Mol Cell Biol; 2004 Sep; 24(17):7435-43. PubMed ID: 15314154
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling.
Johnston AM; Pirola L; Van Obberghen E
FEBS Lett; 2003 Jul; 546(1):32-6. PubMed ID: 12829233
[TBL] [Abstract][Full Text] [Related]
20. Insulin signalling in the heart.
Bertrand L; Horman S; Beauloye C; Vanoverschelde JL
Cardiovasc Res; 2008 Jul; 79(2):238-48. PubMed ID: 18390897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
